What’s Driving the Boom in Early Stage Biotech Funding?

What’s Driving the Boom in Early Stage Biotech Funding?

By • on May 3, 2019

The LabTech website noted that J&J Innovation is one of the many investors that are turning their gaze to the promise of early-stage research.  J&J Innovation is following a strategy focusing on supporting ‘open innovation’, an approach that they believe could work where the traditional pharma approach has failed.  J&J entered a collaboration

Comments Off on What’s Driving the Boom in Early Stage Biotech Funding?Read this story »

More Articles

Vetter Launches Open Innovation Challenge

Vetter Launches Open Innovation Challenge

By • on July 5, 2018

The Pharmabiz website reported that Vetter Pharma International, a leading contract development and manufacturing organization, has launched the Open Innovation Challenge campaign to develop a future-focused and sustainable solutions for the injection of medicines. It is bringing together approximately

Comments Off on Vetter Launches Open Innovation ChallengeRead this story »

Europe has Untapped Medical Innovation

Europe has Untapped Medical Innovation

By • on September 6, 2017

The PharmaPhorum website noted that the ‘open innovation’ strategy is being pursued by all the big pharma companies – and now it’s simply a matter of who executes best on this approach. This is one of the boldest efforts in big pharma to create relationships with entrepreneurs, scientists and

Comments Off on Europe has Untapped Medical InnovationRead this story »

Collaborations Can Make UK a Pharma Leader

Collaborations Can Make UK a Pharma Leader

By • on February 10, 2017

The Pharma Letter website reported that the move away from the older model of closed corporate research and development labs and towards collaborative working and open innovation is highlighted as in the R&D sourcebook from the Association of the British Pharmaceutical Industry (ABPI). “It is therefore

Comments Off on Collaborations Can Make UK a Pharma LeaderRead this story »

Radical Experiment Changing the Way Big Pharma Innovates

Radical Experiment Changing the Way Big Pharma Innovates

By • on July 24, 2016

The Fortune website noted that in the highly competitive, IP-obsessed world of drug development, throwing open the doors and inviting people in, is a departure in strategy to say the least. Yet, such is the surprising concept behind JLABS, the “no strings attached” incubator that Johnson & Johnson

Comments Off on Radical Experiment Changing the Way Big Pharma InnovatesRead this story »

Open Innovation and Big Pharma

Open Innovation and Big Pharma

By • on May 4, 2016

The PMLive website reported that there has been a major drive towards an open innovation model among big pharma companies, seeking to forge closer ties with small biopharma companies and academic groups in recognition that relying on in-house pharma R&D is no longer enough to remain competitive.

Comments Off on Open Innovation and Big PharmaRead this story »

Joel West on Open Innovation

Joel West on Open Innovation

By • on January 13, 2015

The Keck Graduate Institute website reported that Joel West, Henry Chesbrough and Wim Vanhaverbeck recently published a new book, “New Frontiers in Open Innovation.” In an interview with the site Dr. West discusses the approach the three open innovation experts took to covering the extensive

Comments Off on Joel West on Open InnovationRead this story »

AstraZeneca Reinforces Pipeline With Open Innovation

AstraZeneca Reinforces Pipeline With Open Innovation

By • on April 29, 2014

The Telegraph website reported that big pharma giant AstraZeneca has spent the past few years forging partnerships with groups spanning health charities, academic researchers and even its industry rivals. The collaborations work by openly sharing early-stage research, mostly into understanding

Comments Off on AstraZeneca Reinforces Pipeline With Open InnovationRead this story »

The Right Prescription: Open Innovation

The Right Prescription: Open Innovation

By • on October 8, 2013

The Business Standard website reported that the rising cost of drug discovery makes it pertinent to look at alternate models to approach innovation.  The ‘Open Innovation model’ has emerged as an interesting alternative. It is based upon openness and collaboration, which is in complete

Comments Off on The Right Prescription: Open InnovationRead this story »

Big companies Look to Open Innovation

Big companies Look to Open Innovation

By • on October 17, 2012

The Financial Times reports that Unilever, the Anglo-Dutch conglomerate, is trawling the outside world for help in producing an environmentally friendly detergent and sugar-reduced drinks. The move is part of a growing global trend for open innovation

Comments Off on Big companies Look to Open InnovationRead this story »

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.